Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 11/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL822719 | 1.00 | BCHE (0.49) | BCHEALDH1A1MAPTPDE1CCHRM2 | |
| SCHEMBL26205730 | 1.00 | BCHE (0.49) | BCHEALDH1A1MAPTPDE1CCHRM2 | |
| SCHEMBL822521 | 1.00 | BCHE (0.49) | BCHEALDH1A1MAPTPDE1CCHRM2 | |
| SCHEMBL822750 | 1.00 | BCHE (0.49) | BCHEALDH1A1MAPTPDE1CCHRM2 | |
| SCHEMBL16261717 | 1.00 | BCHE (0.49) | BCHEALDH1A1MAPTPDE1CCHRM2 | |
| SCHEMBL822629 | 1.00 | BCHE (0.49) | BCHEALDH1A1MAPTPDE1CCHRM2 | |
| SCHEMBL12199932 | 0.92 | BCHE (0.54) | BCHEALDH1A1MAPTCHRM2MEN1 | |
| SCHEMBL7150802 | 0.92 | BCHE (0.54) | BCHEALDH1A1MAPTCHRM2MEN1 | |
| SCHEMBL7152562 | 0.92 | BCHE (0.54) | BCHEALDH1A1MAPTCHRM2MEN1 | |
| SCHEMBL7276665 | 0.92 | BCHE (0.54) | BCHEALDH1A1MAPTCHRM2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024233598-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2024-11-14 | — | — | WO | disclosed |
| EP-4429763-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | Yewsavin, Inc. (US) | 2024-09-18 | — | — | EP | disclosed |
| US-20240239962-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20230167235-A1 | Polyester Carbonates Having a Defined Proportion of Ester Groups | COVESTRO DEUTSCHLAND AG (DE) | 2023-06-01 | — | — | US | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
| US-20230145772-A1 | Polyester Carbonates Consisting of Different Diols in a Defined Ratio | COVESTRO DEUTSCHLAND AG (DE) | 2023-05-11 | — | — | US | disclosed |
| US-20230052441-A1 | POLYCARBONATE/POLYORGANOSILOXANE COPOLYMER AND RESIN COMPOSITION INCLUDING SAID COPOLYMER | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-02-16 | — | — | US | disclosed |
| US-20230046996-A1 | POLYCARBONATE/POLYORGANOSILOXANE COPOLYMER AND RESIN COMPOSITION INCLUDING SAID COPOLYMER | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-02-16 | — | — | US | disclosed |
| US-20230038766-A1 | POLYCARBONATE/POLYORGANOSILOXANE COPOLYMER AND RESIN COMPOSITION INCLUDING SAID COPOLYMER | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-02-09 | — | — | US | disclosed |
| EP-4071195-A1 | POLYCARBONATE/POLYORGANOSILOXANE COPOLYMER AND RESIN COMPOSITION INCLUDING SAID COPOLYMER | Idemitsu Kosan Co., Ltd (JP) | 2022-10-12 | — | — | EP | disclosed |
| US-8034894-B2 | Terminal modified polycarbonate and manufacturing process thereof | TEIJIN LIMITED (JP) | 2011-10-11 | — | — | US | disclosed |
| US-8008381-B2 | Polycarbonate resin composition | TEIJIN LIMITED (JP) | 2011-08-30 | — | — | US | disclosed |
| US-20100196720-A1 | POLYCARBONATE RESIN AND OPTICAL FILM USING THE SAME | ABB TECHNOLOGY LTD. (CH) | 2010-08-05 | — | — | US | disclosed |
| US-20100184884-A1 | FLAME-RETARDANT POLYCARBONATE RESIN COMPOSITION | TEIJIN LIMITED (JP) | 2010-07-22 | — | — | US | disclosed |
| US-20100160563-A1 | POLYCARBONATE RESIN COMPOSITION | TEIJIN LIMITED (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20100105854-A1 | TERMINAL MODIFIED POLYCARBONATE AND MANUFACTURING PROCESS THEREOF | TEIJIN LIMITED (JP) | 2010-04-29 | — | — | US | disclosed |
| US-20100076130-A1 | POLYCARBONATE RESIN COMPOSITION | TEIJIN LIMITED (JP) | 2010-03-25 | — | — | US | disclosed |
| US-20100048854-A1 | POLYCARBONATE RESIN AND MANUFACTURING PROCESS THEREOF | TEIJIN LIMITED (JP) | 2010-02-25 | — | — | US | disclosed |
| US-20100029678-A1 | DIURETICS | MERCK SHARP & DOHME CORP. | 2010-02-04 | — | — | US | disclosed |
| WO-2008002924-A2 | QUINOXALINYL MACROCYCLIC HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS | ENANTA PHARMACEUTICALS, INC. (US) | 2008-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029678-A1 | DIURETICS | NR3C2, REN, NR3C1 | BCHE 2877/4885ALDH1A1 2059/4885MAPT 4222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.